Late spring gives way to early summer, as all things thrive. On May 24, 2026, the Industry‑University Cooperation and New Factory Launch Ceremony of Anhui AISRI Medical Technology Co., Ltd. was grandly held at Hefei Nanyanhu Science Park. A host of leaders and guests attended the event, including Qiu Zhihai, Member of the Standing Committee of the Party Committee and Vice President of Anhui Medical University; Liu Sheng, Member of the Working Committee and Deputy Director of the Administrative Committee of Hefei Economic and Technological Development Zone; Qian Haisheng, Dean of the School of Biomedical Engineering, Anhui Medical University; Li Yonghuai, Deputy Party Secretary and Executive President of the North Campus of The First Affiliated Hospital of Anhui Medical University; Xu Rongming, Partner of Yida Capital and General Manager of Yida Huicheng; Zhang Songgen, Chairman of Beijing Tinavi Medical Technology Co., Ltd. They gathered to witness this important milestone for integrated development of industry, academia, research, medicine and engineering.

Group photo taken at the launch ceremony

Joining Forces: Four Parties Discuss Collaborative Innovation

Qiu Zhihai (Member of the Standing Committee of the Party Committee and Vice President of Anhui Medical University): Anhui Medical University has jointly built a Medical Robotics Industry College with Tinavi, establishing a mature industry-university collaborative mechanism. AISRI’s participation marks a natural extension of this cooperation system. The university looks forward to jointly cultivating interdisciplinary medical-engineering talents, forming joint research teams and streamlining pathways for commercialization of research outcomes, to set a benchmark for collaborative innovation among universities, hospitals and enterprises.

Liu Sheng (Member of the Working Committee and Deputy Director of the Administrative Committee of Hefei Economic and Technological Development Zone): The life health industry in Hefei Economic and Technological Development Zone is home to over 300 enterprises, with revenue exceeding RMB 40 billion in 2025. The development zone offers bundled support in premises, policies and services to help AISRI achieve rapid local deployment. Going forward, it will continue to deepen cooperation with high-quality enterprises including AISRI to expand and strengthen the life health industrial cluster.

Li Yonghuai (Deputy Party Secretary and Executive President of the North Campus of The First Affiliated Hospital of Anhui Medical University): The North Campus of The First Affiliated Hospital of Anhui Medical University is a top-tier Grade A comprehensive public hospital delivering the province’s highest standard of infectious disease diagnosis and treatment. It will further advance medicine-research-industry collaboration and build a clinical translation platform together with leading enterprises such as AISRI. Leveraging its strengths in respiratory and oncology diagnosis and treatment, the hospital will open up clinical scenarios to build a high-quality platform for clinical trials and clinical application for regional enterprises, accelerating the translation of research into real-world practice.

Xu Rongming (Partner of Yida Capital and General Manager of Yida Huicheng): Yida Capital has invested in more than 100 projects across Anhui. Capital delivers value not only through funding, but also resource empowerment and long-term partnership. It will continue to provide full support in market expansion and brand building. The investment team recognizes AISRI’s pragmatic, professional team culture and long-term business philosophy. It hopes AISRI will achieve steady growth within this favorable ecosystem of Hefei Economic and Technological Development Zone and make greater contributions to the sector.

Zhang Songgen (Chairman of Beijing Tinavi Medical Technology Co., Ltd.): Tinavi’s TiRobot orthopedic surgical robot has been deployed in more than 160,000 clinical procedures, covering over 200 medical institutions across China’s 31 provinces and municipalities. As a holding subsidiary of Tinavi, AISRI serves as the Group’s core platform based in Hefei for translating medical-engineering research results into products. Tinavi and AISRI will push forward industry-university-research cooperation with firm resolve and pragmatic actions.

Empowered by Partnership: New Factory Officially Opens at Nanyanhu Science Park

Since its founding, AISRI Medical has focused on independent R&D of high-end intraoperative imaging devices. The company has obtained two medical device registration certificates and keeps expanding its business scale. To further boost production capacity, guarantee stable delivery and support mass production of new upcoming products, its new factory at Nanyanhu Science Park has been completed and put into operation. The launch of the new factory represents a full upgrade of AISRI’s manufacturing capability and serves as a key carrier for the rollout of this industry-university cooperation.

From technology R&D to product launch, from individual technological breakthroughs to ecosystem collaboration, AISRI Medical is working hand in hand with universities, hospitals, government bodies and investors to build an innovation system featuring deep integration of industry, academia, research and medicine. It explores uncharted territories and lights up the path to better healthcare.